Publications referencing performed MRI Analysis
http://scholar.harvard.edu/mri/publications
(Cline, Lorensen et al. 1990; Colchester, Hawkes et al. 1991; Lemke, Rhodes et al. 1991;
Kikinis, Shenton et al. 1992; Khoury, Guttmann et al. 1994; Guttmann, Ahn et al. 1995;
Hohol, Guttmann et al. 1997; Warfield, Robatino et al. 1998; Guttmann, Kikinis et al.
1999; Khoury, Orav et al. 1999; Kikinis, Guttmann et al. 1999; Guttmann, Benson et al.
2000; Guttmann, Warfield et al. 2000; Khoury, Guttmann et al. 2000; Weiner, Guttmann
et al. 2000; Sperling, Guttmann et al. 2001; Wei, Warfield et al. 2002; Wei, Guttmann et
al. 2004; Database 2005; Liu, Meier et al. 2005; Guttmann, Meier et al. 2006; Meier and
Guttmann 2006; Wu, Warfield et al. 2006; Glanz, Holland et al. 2007; Bakshi, Neema et
al. 2008; Duan, Hildenbrand et al. 2008; Liptak, Berger et al. 2008; Viglietta, Bourcier et
al. 2008; Gauthier, Berger et al. 2009; Gauthier, Glanz et al. 2009; Healy, Ali et al. 2009;
Neema, Arora et al. 2009; Sampat, Berger et al. 2009; Healy, Liguori et al. 2010; Khoury,
Healy et al. 2010; Sampat, Healy et al. 2010; Xia, Chibnik et al. 2010; Liguori, Healy et
al. 2011; Liguori, Meier et al. 2011; Gholipour, Egorova et al. 2012; Holland, Charil et al.
2012; Moodie, Healy et al. 2012; Bove, Musallam et al. 2013; Coronado WM 2013;
Kivisakk, Healy et al. 2013; Xia, Secor et al. 2013; Gandhi, Healy et al. 2013 )
Bakshi, R., M. Neema, et al. (2008). "Predicting clinical progression in multiple sclerosis
with the magnetic resonance disease severity scale." Arch Neurol 65(11): 144953.
Bove, R., A. Musallam, et al. (2013). "No sex-specific difference in disease trajectory in
multiple sclerosis patients before and after age 50." BMC Neurol 13: 73.
Cline, H. E., W. E. Lorensen, et al. (1990). "Three-dimensional segmentation of MR
images of the head using probability and connectivity." J Comput Assist Tomogr
14(6): 1037-45.
Colchester, A. F., D. Hawkes, et al. (1991). Automating segmentation of dual-echo MR
head data. Information Processing in Medical Imaging, Springer Berlin
Heidelberg. 511: 175-187.
Coronado WM, S. V., Egorova S, Khoury SJ, Chitnis T. (2013). "Pituitary Volume
Measurements in Malignant Multiple Sclerosis. ." National Collegiate Research
Conference
Database, B. a. W. s. H. M. S. P. (2005).
Duan, Y., P. G. Hildenbrand, et al. (2008). "Segmentation of subtraction images for the
measurement of lesion change in multiple sclerosis." AJNR Am J Neuroradiol
29(2): 340-6.
Gandhi, R., B. Healy, et al. (2013 ). "Circulating microRNAs as biomarkers for disease
staging in multiple sclerosis." Ann Neurol 73(6): 729-40.
Gauthier, S. A., A. M. Berger, et al. (2009). "Rate of brain atrophy in benign vs early
multiple sclerosis." Arch Neurol 66(2): 234-7.
Gauthier, S. A., B. I. Glanz, et al. (2009). "Incidence and factors associated with
treatment failure in the CLIMB multiple sclerosis cohort study." J Neurol Sci
284(1-2): 116-9.
Gholipour, T., MD, , S. Egorova, PhD, , et al. (2012). MRI Characteristics of Malignant
Multiple Sclerosis. The 64th Annual Meeting of the American Academy of
Neurology.
Glanz, B. I., C. M. Holland, et al. (2007). "Cognitive dysfunction in patients with
clinically isolated syndromes or newly diagnosed multiple sclerosis." Mult Scler
13(8): 1004-10.
Guttmann, C. R., S. S. Ahn, et al. (1995). "The evolution of multiple sclerosis lesions on
serial MR." AJNR Am J Neuroradiol 16(7): 1481-91.
Guttmann, C. R., R. Benson, et al. (2000). "White matter abnormalities in mobilityimpaired older persons." Neurology 54(6): 1277-83.
Guttmann, C. R., R. Kikinis, et al. (1999). "Quantitative follow-up of patients with
multiple sclerosis using MRI: reproducibility." J Magn Reson Imaging 9(4): 50918.
Guttmann, C. R., D. S. Meier, et al. (2006). "Can MRI reveal phenotypes of multiple
sclerosis?" Magn Reson Imaging 24(4): 475-81.
Guttmann, C. R. G., S. K. Warfield, et al. (2000). "Variability of Brain Atrophy
Estimates in Multiple Sclerosis." Proc.Intl.Soc.Mag.Reson.Med. 8(4): 1188.
Healy, B. C., E. N. Ali, et al. (2009). "Smoking and disease progression in multiple
sclerosis." Arch Neurol 66(7): 858-64.
Healy, B. C., M. Liguori, et al. (2010). "HLA B*44: protective effects in MS
susceptibility and MRI outcome measures." Neurology 75(7): 634-40.
Hohol, M. J., C. R. Guttmann, et al. (1997). "Serial neuropsychological assessment and
magnetic resonance imaging analysis in multiple sclerosis." Arch Neurol 54(8):
1018-25.
Holland, C. M., A. Charil, et al. (2012). "The relationship between normal cerebral
perfusion patterns and white matter lesion distribution in 1,249 patients with
multiple sclerosis." J Neuroimaging 22(2): 129-36.
Khoury, S. J., C. R. Guttmann, et al. (1994). "Longitudinal MRI in multiple sclerosis:
correlation between disability and lesion burden." Neurology 44(11): 2120-4.
Khoury, S. J., C. R. Guttmann, et al. (2000). "Changes in activated T cells in the blood
correlate with disease activity in multiple sclerosis." Arch Neurol 57(8): 1183-9.
Khoury, S. J., B. C. Healy, et al. (2010). "A randomized controlled double-masked trial
of albuterol add-on therapy in patients with multiple sclerosis." Arch Neurol
67(9): 1055-61.
Khoury, S. J., E. J. Orav, et al. (1999). "Changes in serum levels of ICAM and TNF-R
correlate with disease activity in multiple sclerosis." Neurology 53(4): 758-64.
Kikinis, R., C. R. Guttmann, et al. (1999). "Quantitative follow-up of patients with
multiple sclerosis using MRI: technical aspects." J Magn Reson Imaging 9(4):
519-30.
Kikinis, R., M. E. Shenton, et al. (1992). "Routine quantitative analysis of brain and
cerebrospinal fluid spaces with MR imaging." J Magn Reson Imaging 2(6): 61929.
Kivisakk, P., B. C. Healy, et al. (2013). "Evaluation of circulating osteopontin levels in
an unselected cohort of patients with multiple sclerosis: relevance for biomarker
development." Mult Scler.
Lemke, H., M. Rhodes, et al. (1991). Segmentation of Dual-Echo MR Head Data.
Computer Assisted Radiology / Computergestützte Radiologie, Springer Berlin
Heidelberg: 606-611.
Liguori, M., B. C. Healy, et al. (2011). "HLA (A-B-C and -DRB1) alleles and brain MRI
changes in multiple sclerosis: a longitudinal study." Genes Immun 12(3): 183-90.
Liguori, M., D. S. Meier, et al. (2011). "One year activity on subtraction MRI predicts
subsequent 4 year activity and progression in multiple sclerosis." J Neurol
Neurosurg Psychiatry 82(10): 1125-31.
Liptak, Z., A. M. Berger, et al. (2008). "Medulla oblongata volume: a biomarker of spinal
cord damage and disability in multiple sclerosis." AJNR Am J Neuroradiol 29(8):
1465-70.
Liu, L., D. Meier, et al. (2005). "Multiple sclerosis medical image analysis and
information management." J Neuroimaging 15(4 Suppl): 103S-117S.
Meier, D. S. and C. R. Guttmann (2006). "MRI time series modeling of MS lesion
development." Neuroimage 32(2): 531-7.
Moodie, J., B. C. Healy, et al. (2012). "Magnetic resonance disease severity scale
(MRDSS) for patients with multiple sclerosis: a longitudinal study." J Neurol Sci
315(1-2): 49-54.
Neema, M., A. Arora, et al. (2009). "Deep gray matter involvement on brain MRI scans
is associated with clinical progression in multiple sclerosis." J Neuroimaging
19(1): 3-8.
Sampat, M. P., A. M. Berger, et al. (2009). "Regional white matter atrophy--based
classification of multiple sclerosis in cross-sectional and longitudinal data." AJNR
Am J Neuroradiol 30(9): 1731-9.
Sampat, M. P., B. C. Healy, et al. (2010). "Disease modeling in multiple sclerosis:
assessment and quantification of sources of variability in brain parenchymal
fraction measurements." Neuroimage 52(4): 1367-73.
Sperling, R. A., C. R. Guttmann, et al. (2001). "Regional magnetic resonance imaging
lesion burden and cognitive function in multiple sclerosis: a longitudinal study."
Arch Neurol 58(1): 115-21.
Viglietta, V., K. Bourcier, et al. (2008). "CTLA4Ig treatment in patients with multiple
sclerosis: an open-label, phase 1 clinical trial." Neurology 71(12): 917-24.
Warfield, S., A. Robatino, et al. (1998). Nonlinear Registration and Template Driven
Segmentation. Brain Warping. A. W. Toga.
Wei, X., C. R. Guttmann, et al. (2004). "Has your patient's multiple sclerosis lesion
burden or brain atrophy actually changed?" Mult Scler 10(4): 402-6.
Wei, X., S. K. Warfield, et al. (2002). "Quantitative analysis of MRI signal abnormalities
of brain white matter with high reproducibility and accuracy." J Magn Reson
Imaging 15(2): 203-9.
Weiner, H. L., C. R. Guttmann, et al. (2000). "Serial magnetic resonance imaging in
multiple sclerosis: correlation with attacks, disability, and disease stage." J
Neuroimmunol 104(2): 164-73.
Wu, Y., S. K. Warfield, et al. (2006). "Automated segmentation of multiple sclerosis
lesion subtypes with multichannel MRI." Neuroimage 32(3): 1205-15.
Xia, Z., L. B. Chibnik, et al. (2010). "A putative Alzheimer's disease risk allele in PCK1
influences brain atrophy in multiple sclerosis." PLoS One 5(11): e14169.
Xia, Z., E. Secor, et al. (2013). "Modeling disease severity in multiple sclerosis using
electronic health records." PLoS One 8(11): e78927.